HONG KONG and SHANGHAI, Oct. 23, 2026 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or the "Company"; Stock Code: 1833.HK) today announced its results for the nine months ended 30 September 2026. During the period, the Company recorded total revenue of RMB3.51billion and net profit of RMB0.25 billion, representing year-on-year growth of 35%.

Core Businesses Remain Solid; Innovative Services Continue to Unlock Value From the "Insurance + Health Care" Synergy

In the commercial insurance enablement business (F-end), the Company focused on enhancing its membership service system, which is deeply integrated with insurance products, improving the differentiated competitiveness of insurance offerings. By enriching healthcare service benefits, the Company also supported customer acquisition through scenario-based insurance marketing. Leveraging its professional medical service capabilities, the Company continued to deepen the application of its "insurance + health care" synergistic model in disease-specific care.

To mark the 33^rd World Alzheimer's Day, the Company jointly launched the Brain Health Service with Ping An Life Insurance, focusing on Alzheimer's disease and offering a full-cycle health management solution spanning screening, treatment, rehabilitation, care & support and payment. The service will gradually expand into broader brain-health areas, including stroke, Parkinson's disease and depression.

In the corporate health management business (B-end), demand for services continues to grow as investment in employee health becomes an increasingly important part of corporate human resources management. As of the end of September this year, the number of paying corporate clients served by the Company over the past 12 months exceeded 8,100, up nearly 60% year on year, while GMV of the corporate health management business continued to increase.

The Company stepped up efforts to acquire corporate clients, broadening its product range and improving service quality to boost conversion across online and offline channels. More tailored, specialized healthcare services are helping expand the commercial potential of its corporate health offerings.

During the period, the Company further strengthened its "online, in-hospital, at-home and corporate" service network and actively introduced third-party service providers to enrich its service and product offerings. The Company also upgraded its Ping An Health Longevity Management Service System, joining forces with more than 40 leading companies to establish a Longevity Management Ecosystem Alliance. It also unveiled 11 Ping An Health Longevity Centers nationwide, building on its 11 self-operated medical facilities and working closely with affiliated providers to create an extensive longevity medicine service network.

AI Capabilities Expand Across Diverse Scenarios and User Groups; Differentiated Deployment Model Earns International Recognition

Ping An Good Doctor continues to deepen the development and real-world deployment of its AI capabilities. Through a "human professionals + AI + ecosystem" closed loop, the Company has built a distinct competitive advantage and steadily improved the quality and efficiency of its professional medical services. During the period, the number of AI Doctor users continued to grow, reaching nearly 13 million.

• For serious medical care, the Company further upgraded its AI-enabled multidisciplinary team ("MDT") assistance platform for complex-disease diagnosis. As of the end of September this year, the platform has covered four major disease categories. The accuracy rate of MDT diagnosis and treatment plans for complex diseases was approximately [90]%, demonstrating the growing use of AI in complex-disease diagnosis and treatment.
• For proactive health management, the Company launched "Ping An Smart Private Coach," a digital health management service that pairs an AI coach with a human personal trainer, creating an exercise and wellness cycle of assessment, training and consolidation.
• For cross-border healthcare, the Company's "Ping An GlobalCare" debuted at the Shenzhen Sci-Tech Innovation Exhibition in September. Combining AI-powered multilingual translation with integrated online and offline services, it provides expatriates in China with one-stop healthcare services, helping address language barriers, complex procedures and gaps in care coordination. The service is now available in Shenzhen.

In addition, Frost & Sullivan has named the Company a key case study in its 2026 Blue Book on the Development of the Global AI Healthcare Industry, citing its established AI healthcare deployment capabilities and full-scenario service ecosystem. The report noted that the Company has evolved from an online healthcare service platform into an AI-driven healthcare service ecosystem platform. Through its "AI + Physician" dual-engine model and a "human professionals + AI + ecosystem" closed loop, the Company has built a distinct competitive advantage and further advanced the integration of AI technology into medical scenarios.

Looking ahead, Ping An Good Doctor will accelerate the use of AI in a wider range of areas, including professional medical services and the development of innovative products that integrate insurance and healthcare services. It will continue to use technology to enhance its healthcare services and senior-care ecosystem, while further expanding its "online, in-hospital, at-home and corporate" service network and strengthening its ability to attract and serve corporate clients. The Company aims to provide professional, comprehensive and high-quality one-stop medical, health and senior care solutions, supporting the development of a multi-tiered health service system.

View original content:https://www.prnewswire.co.uk/news-releases/ping-an-good-doctors-nine-month-net-profit-rises-35-company-accelerates-efforts-to-broaden-ai-applications-in-healthcare-302917736.html

Die an der Schweizer Börse SIX kotierte EEII AG hat für das erste Halbjahr 2026 einen Verlust von 547’568 Franken ausgewiesen. Bereits im zweiten Halbjahr 2025 hatte die Gesellschaft einen Fehlbetrag von 332’306 Franken verbucht. Der Nettoinventarwert (NAV) der EEII-Aktien lag per 30. Juni 2026 bei minus 0.76 Franken je Titel, was einer Verschlechterung um 0.29 Franken pro Aktie seit Jahresbeginn entspricht.

Im Mittelpunkt des Berichtszeitraums standen die Vorbereitungen für eine Reverse-Takeover-Transaktion mit der Jubin Frères SA. EEII hat nach eigenen Angaben die reglementarische Genehmigung der Schweizer Börse erhalten, um eine Kapitalerhöhung durchzuführen und das Unternehmen Jubin Frères zu integrieren. Damit schafft die Gesellschaft die formalen Voraussetzungen, ihren Status als Börsenmantel in eine operative Struktur zu überführen.

Operativ verfügt EEII derzeit über keine aktive Investition. Dennoch fielen für den Erhalt der Struktur als kotierte Gesellschaft im ersten Halbjahr 2026 Kosten von rund 128’479 Franken an. Hinzu kamen Aufwendungen von 419’089 Franken für die Erstellung des Prospekts und dessen Einreichung bei der SIX. Zusammengenommen summierten sich die gesamten Betriebsaufwendungen auf 547’568 Franken und entsprechen damit vollständig dem ausgewiesenen Verlust.

Der Halbjahresbericht 2026 ist über die Website des Unternehmens abrufbar. EEII ist an der SIX kotiert (Bloomberg: EEII SW Equity). Das Unternehmen betont, dass die veröffentlichten Informationen ausschliesslich zu Informationszwecken dienen und weder ein Angebot noch eine Aufforderung oder Empfehlung zum Kauf oder Verkauf von Wertpapieren der EEII AG darstellen.